BRAFV600E mutations in serous ovarian cancer and response to the BRAF inhibitor, dabrafenib. Conference Paper uri icon

authors

  • DeFazio, A
  • Moujaber, T
  • Etemadmoghadam, D
  • Kennedy, C
  • Chiew, Y-E
  • Balleine, RL
  • Saunders, C
  • Wain, GV
  • Dobrovic, A
  • Bowtell, DDL
  • Harnett, PR

publication date

  • January 15, 2016